Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.

by Hind Alnajashi, Razan Jabbad
Published 2020-01-01

Prevalence of antinuclear antibody in patients with multiple sclerosis: a case-control study

by Hind Alnajashi, Foziah Alshamrani
Published 2021-02-01

Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum

by Foziah Alshamrani, Hind Alnajashi, Eslam Shosha, Courtney Casserly, Sarah A. Morrow
Published 2020-02-01

A prospective study comparing injectable interferon beta-1a (Rebif 22-44), (Avonex 30) and 1b (Betaseron 250) injection site reaction in multiple sclerosis patients

by Foziah Jabbar Alshamrani, Hind Alnajashi, Fahad Alkhamis, Ibrahim Alghanimi, Abdulla Alsulaiman, Aishah Albaker, Iqbal bukari, Amir Mohamad
Published 2019-09-01